We think EssilorLuxottica will benefit from intangible assets (strong brands, distribution channel access, and research and development platforms) and cost advantage, enabling it to generate economic profits well into the future.
EssilorLuxottica is the leader in the fragmented eyewear industry, more than twice the size of the next-biggest player, which allows manufacturing at scale.
As a serial acquirer EssilorLuxottica faces operational risk when integrating targets.
|
Metric
|
EL
|
COO
|
|---|---|---|
Price/Earnings (Normalized) | 29.89 | 27.19 |
Price/Book Value | 2.42 | 2.33 |
Price/Sales | 3.63 | 4.92 |
Price/Cash Flow | 17.34 | 20.88 |
|
Metric
|
EL
|
COO
|
|---|---|---|
Quick Ratio | 0.63 | 0.81 |
Current Ratio | 1.00 | 1.86 |
Interest Coverage | 15.90 | 4.77 |
|
Metric
|
EL
|
COO
|
|---|---|---|
Return on Assets (Normalized) | 4.87% | 2.49% |
Return on Equity (Normalized) | 7.79% | 3.88% |
Return on Invested Capital (Normalized) | 6.03% | 3.63% |
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Kyglvmckc | Jpsb | $129.9 Bil | |
BDX
| Becton Dickinson & Co | Dlsmbfd | Wjctgy | $67.6 Bil | |
ALC
| Alcon Inc | Wgtgrdq | Frbjkx | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Ywfqbdbv | Jvhq | $28.8 Bil | |
WST
| West Pharmaceutical Services Inc | Yldtxypkr | Qzbwc | $27.6 Bil | |
RMD
| ResMed Inc | Fmvrjcvhv | Jtsqfn | $26.1 Bil | |
BAX
| Baxter International Inc | Gqhkmcpl | Mjnbnt | $20.2 Bil | |
COO
| The Cooper Companies Inc | Cnzxhsqh | Zlmvxw | $18.0 Bil | |
HOLX
| Hologic Inc | Gddjjzhpm | Yjfstrc | $17.7 Bil | |
TFX
| Teleflex Inc | Sjvzz | Mrl | $9.7 Bil |
